Articles

The TGA has granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19.

TGA compliance and enforcement in 2019-20

From 1 July 2020 medicine ads in specified media no longer require pre-approval

The TGA has issued an infringement notice for $12,600 to Sydney-based company Arborvitae Health and Wellbeing for alleged unlawful advertising in relation to COVID-19.

The TGA has issued two infringement notices totalling $25,200 to Sydney-based company Pfeffer Contracting for alleged unlawful advertising in relation to COVID-19.

The TGA has issued two infringement notices totalling $25,200 to Sydney-based company Australian Chemical Research

The TGA has issued three infringement notices totalling $7,560 to a woman based in Brisbane

No lasting increase in consumption following up-scheduling of low-dose products

Reminder of changes for those who advertise medicines to the public using television, radio, print media, cinema, billboards or other public displays

The TGA has commenced a review of complaints received alleging non-compliant advertising of medicinal cannabis products to the public

The International Coalition of Medicines Regulatory Authorities aims to provide healthcare professionals with important messages regarding vaccines

The International Coalition of Medicines Regulatory Authorities highlights the importance of vaccines for consumers

The TGA has issued two infringement notices to Sydney-based company Inskin Cosmedics Group Pty Ltd

Net Pharmacy fined $214,200 for alleged unlawful advertising

The TGA has issued twelve infringement notices to a Victorian-based pharmacist for alleged unlawful advertising of therapeutic goods

The TGA has issued five infringement notices to Sydney-based company Chemforce Pty Ltd

TGA taking action on sunscreens tested by AMA Laboratories

The TGA has issued four infringement notices totalling $50,400 to Cairns based company Hydrogen Technologies Pty Ltd for alleged advertising breaches including reference to COVID-19

The Federal Court of Australia has made orders restraining MMS Australia from advertising and supplying goods containing certain potentially dangerous substances until a further hearing next week

The reforms will enable the safe and effective prescribing and use of opioids while maintaining access for patients who need them.

The TGA has initiated proceedings in the Federal Court of Australia in response to the alleged unlawful advertising of Miracle Mineral Supplement (MMS), dimethyl sulfoxide (DMSO) and other medicines by Southern Cross Directories Pty Ltd trading as MMS Australia

The TGA is reminding advertisers that therapeutic goods advertising must not undermine public health campaigns, as the cold and flu season begins in Australia and COVID-19 restrictions are eased

The TGA has issued four infringement notices totalling $50,400 to Brisbane based company Allpulse Technologies Pty Ltd

The TGA has issued a $12,600 infringement notice to Melbourne based company NutriPATH Pty Ltd for the alleged unlawful advertising of a COVID-19 Polymerase Chain Reaction (PCR) test collection kit.

The TGA has issued fifteen infringement notices totalling $37,800 to a doctor in Perth